ArticleBritish journal of cancer2018

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.

Natalie Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.